Title:
CELL PREPARATION
Document Type and Number:
WIPO Patent Application WO/2023/181830
Kind Code:
A1
Abstract:
Provided is a cell preparation that has effective therapeutic effect on ischemic diseases. The cell preparation contains CD18-positive cells. This cell preparation is produced by: acquiring a buffy coat layer from a sample containing hematopoietic stem cells; removing inhibitory cells that inhibit the therapeutic effect from the buffy coat layer to acquire mononuclear cells; acquiring CD34+ mononuclear cells that are CD34-positive from the mononuclear cells; and then acquiring CD34+CD18high mononuclear cells that highly express CD18 from the CD34-positive mononuclear cells.
More Like This:
Inventors:
TAGUCHI AKIHIKO (JP)
OKINAKA YUKA (JP)
OGAWA YUKO (JP)
KIMURA TAKAFUMI (JP)
TANAKA MITSUNOBU (JP)
YASUI KAZUTA (JP)
FUCHIZAKI AKIHIRO (JP)
OKINAKA YUKA (JP)
OGAWA YUKO (JP)
KIMURA TAKAFUMI (JP)
TANAKA MITSUNOBU (JP)
YASUI KAZUTA (JP)
FUCHIZAKI AKIHIRO (JP)
Application Number:
PCT/JP2023/007766
Publication Date:
September 28, 2023
Filing Date:
March 02, 2023
Export Citation:
Assignee:
FOUNDATION FOR BIOMEDICAL RES AND INNOVATION AT KOBE (JP)
International Classes:
A61K35/12; A61K35/28; A61K35/51; A61P25/00; A61P25/16; A61P25/18; A61P25/24; A61P25/28; A61P43/00; C12N5/0735; C12N5/074; C12N5/0775; C12N5/0789; C12N5/0797; C12N5/10
Foreign References:
US20070248998A1 | 2007-10-25 | |||
US20070031387A1 | 2007-02-08 |
Other References:
AKIHIKO TAGUCHI, TOSHIHIRO SOMA, HIDEKAZU TANAKA, TAKAYOSHI KANDA, HIROYUKI NISHIMURA, HIROO YOSHIKAWA, YOSHITANE TSUKAMOTO, HIROY: "Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model", THE JOURNAL OF CLINICAL INVESTIGATION, vol. 114, no. 3, 1 August 2004 (2004-08-01), GB , pages 330 - 338, XP008146070, ISSN: 0021-9738, DOI: 10.1172/JCI20622
MESA-NÚÑEZ CRISTINA, LEON-RICO DIEGO, ALDEA MONTSERRAT, DAMIÁN CARLOS, SANCHEZ-BALTASAR RAQUEL, SANCHEZ REBECA, ALBERQUILLA OMAIRA: "The downregulated membrane expression of CD18 in CD34+ cells defines a primitive population of human hematopoietic stem cells", STEM CELL RESEARCH & THERAPY, vol. 11, no. 1, 1 December 2020 (2020-12-01), pages 1 - 9, XP093095764, DOI: 10.1186/s13287-020-01672-0
MESA-NÚÑEZ CRISTINA, LEON-RICO DIEGO, ALDEA MONTSERRAT, DAMIÁN CARLOS, SANCHEZ-BALTASAR RAQUEL, SANCHEZ REBECA, ALBERQUILLA OMAIRA: "The downregulated membrane expression of CD18 in CD34+ cells defines a primitive population of human hematopoietic stem cells", STEM CELL RESEARCH & THERAPY, vol. 11, no. 1, 1 December 2020 (2020-12-01), pages 1 - 9, XP093095764, DOI: 10.1186/s13287-020-01672-0
Attorney, Agent or Firm:
MAEDA & PARTNERS (JP)
Download PDF:
Previous Patent: TRANSPORT SYSTEM
Next Patent: RESIN COMPOSITION, ADHESIVE OR ENCAPSULATION MATERIAL, CURED OBJECT, SEMICONDUCTOR DEVICE, AND ELECT...
Next Patent: RESIN COMPOSITION, ADHESIVE OR ENCAPSULATION MATERIAL, CURED OBJECT, SEMICONDUCTOR DEVICE, AND ELECT...